162 related articles for article (PubMed ID: 15378847)
1. Validated RP-hPLC method for the assay of zalcitabine in drug substance, formulated products and human serum.
Uslu B; Savaşer A; Ozkan SA; Ozkan Y
Pharmazie; 2004 Aug; 59(8):604-7. PubMed ID: 15378847
[TBL] [Abstract][Full Text] [Related]
2. A validated RP-HPLC method for the determination of mosapride citrate in bulk drug samples and pharmaceutical formulations.
Krishnaiah YS; Murthy TK; Sankar DG; Satyanarayana V
Pharmazie; 2002 Dec; 57(12):814-6. PubMed ID: 12561242
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a HPLC-UV method for the determination in didanosine tablets.
de Oliveira AM; Löwen TC; Cabral LM; dos Santos EM; Rodrigues CR; Castro HC; dos Santos TC
J Pharm Biomed Anal; 2005 Jul; 38(4):751-6. PubMed ID: 15967304
[TBL] [Abstract][Full Text] [Related]
4. Determination of 2',3'-dideoxycytidine in maternal plasma, amniotic fluid, placental and fetal tissues by high-performance liquid chromatography.
Ding Y; Williamson LN; White CA; Bartlett MG
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(2):183-9. PubMed ID: 15522719
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a HPLC method for the determination of cetirizine in pharmaceutical dosage forms.
Paw B; Misztal G; Hopkała H; Drozd J
Pharmazie; 2002 May; 57(5):313-5. PubMed ID: 12061254
[TBL] [Abstract][Full Text] [Related]
6. Determination of leflunomide in tablets by high performance liquid chromatography.
Yeniceli D; Dogrukol-Ak D; Tuncel M
J Pharm Biomed Anal; 2006 Jan; 40(1):197-201. PubMed ID: 16112831
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of RP-HPLC method for the analysis of metformin.
Arayne MS; Sultana N; Zuberi MH
Pak J Pharm Sci; 2006 Jul; 19(3):231-5. PubMed ID: 16935831
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form by RP-HPLC method.
A K; G S; C MR; Bhat K; A R; P M; M S; K K; N U
Pak J Pharm Sci; 2008 Oct; 21(4):421-5. PubMed ID: 18930865
[TBL] [Abstract][Full Text] [Related]
9. A validated method for the analysis of diltiazem in raw materials and pharmaceutical formulations by rp-HPLC.
Sultana N; Arayne MS; Shafi N
Pak J Pharm Sci; 2007 Oct; 20(4):284-90. PubMed ID: 17604250
[TBL] [Abstract][Full Text] [Related]
10. Isocratic RP-HPLC method for rutin determination in solid oral dosage forms.
Kuntić V; Pejić N; Ivković B; Vujić Z; Ilić K; Mićić S; Vukojević V
J Pharm Biomed Anal; 2007 Jan; 43(2):718-21. PubMed ID: 16920326
[TBL] [Abstract][Full Text] [Related]
11. A rapid, sensitive high performance liquid chromatographic method for the determination of meropenem in pharmaceutical dosage form, human serum and urine.
Ozkan Y; Küçükgüzel I; Ozkan SA; Aboul-Enein HY
Biomed Chromatogr; 2001 Jun; 15(4):263-6. PubMed ID: 11438968
[TBL] [Abstract][Full Text] [Related]
12. Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies.
Oliveira DC; Weigch A; Rolim CM
Pharmazie; 2007 Feb; 62(2):96-100. PubMed ID: 17341026
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation.
Mostafavi A; Abedi G; Jamshidi A; Afzali D; Talebi M
Talanta; 2009 Feb; 77(4):1415-9. PubMed ID: 19084658
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an accurate HPLC method for the quantitative determination of picroside II in tablets.
Cheng S; Huang J; He J
Pharmazie; 2007 Aug; 62(8):577-9. PubMed ID: 17867550
[TBL] [Abstract][Full Text] [Related]
15. Determination of cetirizine dihydrochloride, related impurities and preservatives in oral solution and tablet dosage forms using HPLC.
Jaber AM; Al Sherife HA; Al Omari MM; Badwan AA
J Pharm Biomed Anal; 2004 Oct; 36(2):341-50. PubMed ID: 15496327
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of buclizine hydrochloride in pharmaceutical formulations and human serum by RP-HPLC.
Arayne MS; Sultana N; Siddiqui FA
Pak J Pharm Sci; 2006 Oct; 19(4):326-9. PubMed ID: 17105713
[TBL] [Abstract][Full Text] [Related]
17. Relevance of a combined UV and single mass spectrometry detection for the determination of tenofovir in human plasma by HPLC in therapeutic drug monitoring.
El Barkil M; Gagnieu MC; Guitton J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):192-7. PubMed ID: 17499565
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantification of stavudine, lamivudine and nevirapine by UV spectroscopy, reverse phase HPLC and HPTLC in tablets.
Anbazhagan S; Indumathy N; Shanmugapandiyan P; Sridhar SK
J Pharm Biomed Anal; 2005 Sep; 39(3-4):801-4. PubMed ID: 15950425
[TBL] [Abstract][Full Text] [Related]
19. Stability-indicating methods for the determination of piretanide in presence of the alkaline induced degradates.
Youssef NF
J Pharm Biomed Anal; 2005 Oct; 39(5):871-6. PubMed ID: 16223647
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a RP-HPLC method for simultaneous estimation of naproxen and ranitidinehydrochloride.
Haque T; Talukder MM; Laila S; Fatema K
Pak J Pharm Sci; 2010 Oct; 23(4):379-83. PubMed ID: 20884450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
